新ペニシリン系抗生剤TA-058の臨床効果の検討

澤田 博義; 小西 博; 臼井 忠男; 石倉 浩人; 和泉 洋一郎; 望月 敏弘; 内野 治人; 島田 恒治

doi:10.11250/chemotherapy1953.32.Supplement2_334

CLINICAL STUDIES ON THE NEW PENICILLIN DERIVATIVE (TA-058) IN THE FIELD OF INTERNAL MEDICINE

HIROYOSHI SAWADA, HIROSHI KONISHI, TADAO USUI, HIROTO ISHIKURA, YOICHIRO IZUMI, TOSHIHIRO MOCHIZUKI, HARUTO UCHINO, KOJI SHIMADA

Author information

HIROYOSHI SAWADA
The First Division of Internal Medicine, Faculty of Medicine, Kyoto University
HIROSHI KONISHI
The First Division of Internal Medicine, Faculty of Medicine, Kyoto University
TADAO USUI
The First Division of Internal Medicine, Faculty of Medicine, Kyoto University
HIROTO ISHIKURA
The First Division of Internal Medicine, Faculty of Medicine, Kyoto University
YOICHIRO IZUMI
The First Division of Internal Medicine, Faculty of Medicine, Kyoto University
TOSHIHIRO MOCHIZUKI
The First Division of Internal Medicine, Faculty of Medicine, Kyoto University
HARUTO UCHINO
The First Division of Internal Medicine, Faculty of Medicine, Kyoto University
KOJI SHIMADA
Department of Internal Medicine, Shimada City Hospital

JOURNAL FREE ACCESS

1984 Volume 32 Issue Supplement2 Pages 334-338

DOI https://doi.org/10.11250/chemotherapy1953.32.Supplement2_334

Details

Abstract

The new penicillin antibiotic TA-058 was applied to 10 cases with varieus infections. Excellent or good results were obtained in 3 of 4 cases with pulmonary infections, all 3 cases with urinary tract infections, one case with cholecystitis and a leukemic patient with fever, and a case with severe tonsillitis, bronchitis and cystitis. No side effect was observed.
It is expected that this antibiotic may constitute an advance in the antibiotic treatment of gram-positive and gram-negative infections.

Corresponding author

Register with J-STAGE for free!